Cargando…
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis
In AIDS Clinical Trials Group study A5375, a pharmacokinetic trial of levonorgestrel emergency contraception, double-dose levonorgestrel (3 mg, versus standard dose 1.5 mg) offset the induction effects of efavirenz or rifampin on plasma levonorgestrel exposure over 8 h post-dose (AUC(0-8h)). We char...
Autores principales: | Agyemang, Nana, Scarsi, Kimberly K., Baker, Paxton, Smeaton, Laura M., Podany, Anthony T., Olefsky, Maxine, Woolley, Elizabeth, Barr, Elizabeth, Pham, Michelle, Mawlana, Sajeeda, Supparatpinyo, Khuanchai, Gatechompol, Sivaporn, Jalil, Emilia M., Gadama, Luis, Badal-Faesen, Sharlaa, Van Schalkwyk, Marije, Kayama, Cecelia, Belaunzaran-Zamudio, Pablo F., Godfrey, Catherine, Cohn, Susan E., Mngqibisa, Rosie, Haas, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309098/ https://www.ncbi.nlm.nih.gov/pubmed/37306344 http://dx.doi.org/10.1097/FPC.0000000000000501 |
Ejemplares similares
-
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)—report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group
por: Lalloo, Umesh G., et al.
Publicado: (2023) -
In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel
por: Roberts, Owain, et al.
Publicado: (2021) -
Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household
por: Kim, Soyeon, et al.
Publicado: (2023) -
365. Neurocognitive Function Change after Switching from Efavirenz to Rilpivirine in HIV-Infected Adults: A Randomized Control Trial
por: Kaewpoowat, Quanhathai, et al.
Publicado: (2019) -
Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a
sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)